Amwill Health Care (BOM:544353) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544353 Amwill Health Care Ltd BOM:544353
42 GF Score
Price ₹43.24
! 3 Warning Signs
View Full Analysis

What is Amwill Health Care Research & Development?

Amwill Health Care BOM:544353 +0.56% 42 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Amwill Health Care's Research & Development for the six months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Amwill Health Care  (BOM:544353) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Amwill Health Care Research & Development Related Terms

Amwill Health Care Research & Development Historical Data

* Premium members only.

The historical data trend for Amwill Health Care's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amwill Health Care Research & Development Chart

Amwill Health Care Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Amwill Health Care Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BOM:544353
42GF Score
Amwill Health Care Ltd BOM:544353
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amwill Health Care Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Amwill Health Care (BOM:544353) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Amwill Health Care and its competitors.
Is Amwill Health Care's Research & Development too high?
Amwill Health Care's current Research & Development is ₹0.0 Mil. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's Research & Development compare to MCK and COR?
Amwill Health Care's Research & Development of ₹0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Amwill Health Care and its competitors. Amwill Health Care's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current Research & Development of ₹0.0 Mil. The current Research & Development is ₹0.0 Mil. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amwill Health Care Business Description

Address 2nd Main Road, No. 90, 4th Floor, 7th Cross, Chamrajpet, Bangalore, KA, IND, 560 018
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score

Get the complete analysis for BOM:544353

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.24
Price